New Zealand Expands Patient Access to Funded MS Treatments

New Zealand Expands Patient Access to Funded MS Treatments

286887

New Zealand Expands Patient Access to Funded MS Treatments

New Zealand will expand patient access to a list of funded treatments for multiple sclerosis (MS), starting on March 1. The government health agency, PHARMAC, will extend eligibility criteria to include MS patients with expanded disability status scale (EDSS) scores ranging from zero to six. EDSS is a validated tool to assess the levels of disability and disease progression in people with MS. Patients within this EDSS range include those not showing any signs of…

You must be logged in to read/download the full post.